Patterns and rates of exonic de novo mutations in autism spectrum disorders.

Benjamin Neale 1, 2 Yan Kou 3, 4 Li Liu 5 Avi Ma'Ayan 3 Kaitlin E Samocha 2, 1 Aniko Sabo 6 Chiao-Feng Lin 7 Christine Stevens 2 Li-San Wang 7 Vladimir Makarov 4, 8 Paz Polak 2, 9 Seungtai Yoon 4, 8 Jared Maguire 2 Emily Crawford 10 Nicholas Campbell 10 Evan Geller 7 Otto Valladares 7 Chad Schafer 5 Han Liu 11 Tuo Zhao 11 Guiqing Cai 4, 8 Jayon Lihm 4, 8 Ruth Dannenfelser 3 Omar Jabado 12 Zuleyma Peralta 12 Uma Nagaswamy 6 Donna Muzny 6 Jeffrey Reid 6 Irene Newsham 6 Yuanqing Wu 6 Lora Lewis 6 Yi Han 6 Benjamin Voight 2, 13 Elaine Lim 1, 2 Elizabeth Rossin 1, 2 Andrew Kirby 1, 2 Jason Flannick 2 Menachem Fromer 1, 2 Khalid Shakir 2 Tim Fennell 2 Kiran Garimella 2 Eric Banks 2 Ryan Poplin 2 Stacey Gabriel 2 Mark Depristo 2 Jack Wimbish 14 Braden Boone 14 Shawn Levy 14 Catalina Betancur 15 Shamil Sunyaev 2, 9 Eric Boerwinkle 6, 16 Joseph Buxbaum 4, 8, 12, 17, * Edwin Cook 18 Bernie Devlin 19 Richard Gibbs 6 Kathryn Roeder 5, * Gerard Schellenberg 7 James Sutcliffe 10 Mark Daly 1, 2, *
Abstract : Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.
Type de document :
Article dans une revue
Nature, Nature Publishing Group, 2012, 485 (7397), pp.242-5. 〈10.1038/nature11011〉
Liste complète des métadonnées

Littérature citée [18 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00939274
Contributeur : Catalina Betancur <>
Soumis le : jeudi 30 janvier 2014 - 15:02:48
Dernière modification le : jeudi 11 janvier 2018 - 06:22:24
Document(s) archivé(s) le : lundi 5 mai 2014 - 11:11:21

Fichiers

Neale-main_text.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Benjamin Neale, Yan Kou, Li Liu, Avi Ma'Ayan, Kaitlin E Samocha, et al.. Patterns and rates of exonic de novo mutations in autism spectrum disorders.. Nature, Nature Publishing Group, 2012, 485 (7397), pp.242-5. 〈10.1038/nature11011〉. 〈inserm-00939274〉

Partager

Métriques

Consultations de la notice

582

Téléchargements de fichiers

1330